Magnolia Capital Advisors Llc
Source: SEC Form 13F · as of Mar 2026Magnolia Capital Advisors Llc holds 19 biotech & pharma companies tracked by BioSniper, totaling $22.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$22.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,885 | $4.5M |
| MRKMerck & Co., Inc. | 34,804 | $4.2M |
| ABBVAbbVie Inc. | 14,887 | $3.2M |
| JNJJOHNSON & JOHNSON | 12,734 | $3.1M |
| ZTSZoetis Inc. | 12,079 | $1.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,437 | $1.2M |
| AMGNAMGEN INC | 2,434 | $856K |
| IQVIQVIA Holdings Inc. | 3,803 | $649K |
| ABTABBOTT LABORATORIES | 5,909 | $607K |
| DMACDiaMedica Therapeutics Inc. | 77,405 | $524K |
| GILDGILEAD SCIENCES, INC. | 3,320 | $463K |
| PFEPFIZER INC | 15,560 | $437K |
| VKTXViking Therapeutics, Inc. | 12,115 | $394K |
| MCKMcKesson Corporation | 337 | $292K |
| BMYBRISTOL MYERS SQUIBB CO | 4,300 | $261K |
| PMPhilip Morris International Inc | 1,487 | $246K |
| PGENPRECIGEN, INC. | 36,531 | $141K |
| ACHVACHIEVE LIFE SCIENCES, INC. | 24,100 | $71K |
| CGENCOMPUGEN LTD | 25,000 | $53K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.